<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-06T08:47:22Z</responseDate>
  <request identifier="oai:figshare.com:article/34072460" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34072460</identifier>
        <datestamp>2026-10-05T17:36:56Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_140</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>BioDRUMs: An Open-Source Python Pipeline for Automated
Mean Drug-to-Antibody Ratio and Biologics Structural Integrity Analysis
from High-Resolution Mass Spectrometry Data</dc:title>
          <dc:creator>Andrea Di Ianni (17987730)</dc:creator>
          <dc:creator>Francesco Molinaro (25316999)</dc:creator>
          <dc:creator>Luca M. Barbero (17987739)</dc:creator>
          <dc:creator>Kyra Cowan (17987736)</dc:creator>
          <dc:creator>Federico Riccardi Sirtori (1999360)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Cardiology</dc:subject>
          <dc:subject>web app interface</dc:subject>
          <dc:subject>prior programming knowledge</dc:subject>
          <dc:subject>existing coding skills</dc:subject>
          <dc:subject>deep adc characterization</dc:subject>
          <dc:subject>deconvoluted mass tables</dc:subject>
          <dc:subject>data processing represent</dc:subject>
          <dc:subject>mass spectrometric analysis</dc:subject>
          <dc:subject>streamlining data analysis</dc:subject>
          <dc:subject>simplify data analysis</dc:subject>
          <dc:subject>source python pipeline</dc:subject>
          <dc:subject>automated python pipeline</dc:subject>
          <dc:subject>species ambiguity reporting</dc:subject>
          <dc:subject>graphical user interface</dc:subject>
          <dc:subject>si &lt;/ u</dc:subject>
          <dc:subject>r &lt;/ u</dc:subject>
          <dc:subject>bio &lt;/ u</dc:subject>
          <dc:subject>automated mean drug</dc:subject>
          <dc:subject>structural integrity analysis</dc:subject>
          <dc:subject>u &lt;/ u</dc:subject>
          <dc:subject>source pipeline</dc:subject>
          <dc:subject>plot data</dc:subject>
          <dc:subject>mean drug</dc:subject>
          <dc:subject>automated plotting</dc:subject>
          <dc:subject>vivo &lt;/</dc:subject>
          <dc:subject>vitro &lt;/</dc:subject>
          <dc:subject>&lt;/ u</dc:subject>
          <dc:subject>structural integrity</dc:subject>
          <dc:subject>integrity scoring</dc:subject>
          <dc:subject>mean dar</dc:subject>
          <dc:subject>drug conjugates</dc:subject>
          <dc:subject>without requiring</dc:subject>
          <dc:subject>sample preparation</dc:subject>
          <dc:subject>relatively robust</dc:subject>
          <dc:subject>overall interpretation</dc:subject>
          <dc:subject>nified intact</dc:subject>
          <dc:subject>new candidate</dc:subject>
          <dc:subject>neutral postprocessing</dc:subject>
          <dc:subject>limiting steps</dc:subject>
          <dc:subject>hypothesis generation</dc:subject>
          <dc:subject>first time</dc:subject>
          <dc:subject>different vendors</dc:subject>
          <dc:subject>different operators</dc:subject>
          <dc:subject>different laboratories</dc:subject>
          <dc:subject>customizable degradation</dc:subject>
          <dc:subject>complex modalities</dc:subject>
          <dc:subject>automated open</dc:subject>
          <dc:subject>ass analy</dc:subject>
          <dc:description>Drug-to-antibody
ratio and structural integrity represent two critical
quality attributes for antibody-drug conjugates and multispecific
biologics in development. Intact mass spectrometry analysis of biologics
is crucial to understanding the behavior of a new candidate, especially
for complex modalities. Sample preparation is relatively robust and
easy to reproduce in different laboratories and by different operators.
However, mass spectrometric analysis and data processing represent
the two most limiting steps. So far, no automated open-source pipeline
has been published, which can automatically postprocess deconvoluted
spectrum outputs from different vendors, plot data, and provide an
overall interpretation of mean DAR and deep ADC characterization,
especially on &lt;i&gt;in vivo&lt;/i&gt; samples. BioDRUMs offers different
features that complement existing commercial mass spectrometry deconvolution
tools, such as customizable degradation-hypothesis generation, isobaric-species
ambiguity reporting, vendor-neutral postprocessing of deconvoluted
mass tables, structural-integrity scoring, automated plotting, and
reporting. Streamlining data analysis of the mean drug-to-antibody
ratio and structural integrity can accelerate and provide uniform
data outputs and result delivery across different &lt;i&gt;in vitro&lt;/i&gt;/&lt;i&gt;in vivo&lt;/i&gt; studies. Moreover, a user-friendly pipeline
would enable scientists to perform such an analysis for the first
time more confidently, without requiring any pre-existing coding skills.
In this work, we present BioDRUMs (&lt;u&gt;Bio&lt;/u&gt;logics &lt;u&gt;D&lt;/u&gt;rug &lt;u&gt;R&lt;/u&gt;atio and &lt;u&gt;U&lt;/u&gt;nified intact &lt;u&gt;M&lt;/u&gt;ass analy&lt;u&gt;si&lt;/u&gt;s), an automated Python pipeline to simplify data analysis of the
mean drug-to-antibody ratio and structural integrity analysis of biologics
and bioconjugates. A graphical user interface (GUI) and a Web app
interface have also been implemented to make it user-friendly for
users with little to no prior programming knowledge.</dc:description>
          <dc:date>2026-10-05T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/jasms.6c00289.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/BioDRUMs_An_Open-Source_Python_Pipeline_for_Automated_Mean_Drug-to-Antibody_Ratio_and_Biologics_Structural_Integrity_Analysis_from_High-Resolution_Mass_Spectrometry_Data/34072460</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
